InsideArbitrage Event Driven Monitor – January 26, 2024

Merger Arbitrage

1. RYZB: Bristol-Myers Squibb (BMY) and RayzeBio (RYZB) intend to file on January 25, 2024, a premerger notification and report form under the HSR Act with the Antitrust Division and the FTC. The initial expiration date of the tender offer is February 22, 2024.
2. CSTR: Old National (ONB) and CapStar (CSTR) need to obtain consents including approvals from the Federal Reserve Board and the OCC.
3. IMGN: ImmunoGen (IMGN) and AbbVie (ABBV) filed a notification with respect to the merger with the German Federal Cartel Office (the “FCO”) on January 11, 2024.

You can check out new deals, all deal updates, and spreads on active deals in our Merger Arbitrage Tool for premium members here.

Only plus or premium subscribers can access this post. Subscribe today.